Shane Brauner Net Worth

The estimated Net Worth of Shane Brauner is at least $1.12 Milhão dollars as of 22 December 2020. Mr. Brauner owns over 2,000 units of Schrodinger stock worth over $511,763 and over the last 5 years he sold SDGR stock worth over $607,300. In addition, he makes $0 as Senior Vice President e Chief Information Officer at Schrodinger.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Brauner SDGR stock SEC Form 4 insiders trading

Shane has made over 4 trades of the Schrodinger stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 2,000 units of SDGR stock worth $170,000 on 22 December 2020.

The largest trade he's ever made was exercising 24,776 units of Schrodinger stock on 11 November 2020 worth over $67,143. On average, Shane trades about 5,629 units every 7 days since 2020. As of 22 December 2020 he still owns at least 24,867 units of Schrodinger stock.

You can see the complete history of Mr. Brauner stock trades at the bottom of the page.

Shane Brauner biography

Shane Brauner serves as Senior Vice President, Chief Information Officer of the Company. Mr. Brauner has been with our company for over 10 years and previously served as our senior vice president, information systems from January 2017 to January 2019, vice president, information technology and operations from January 2015 to January 2017, executive director, information technology and operations from January 2014 to January 2015, senior director, information technology from January 2012 to January 2014, director, information technology from January 2010 to January 2012 and manager, information technology from February 2009 to January 2010. Prior to joining our company, Mr. Brauner served as a consultant, managing global grid computing support at Pfizer, Inc., or Pfizer, from June 2007 to October 2008. Mr. Brauner received a B.S. in Computer Science from the University of Houston.

How old is Shane Brauner?

Shane Brauner is 42, he's been the Senior Vice President e Chief Information Officer of Schrodinger since 2019. There are 19 older and 3 younger executives at Schrodinger. The oldest executive at Schrodinger, Inc. is Dr. Richard A. Friesner, 68, who is the Co-Founder, Scientific Advisory Chairman and Director.

What's Shane Brauner's mailing address?

Shane's mailing address filed with the SEC is C/O SCHRODINGER, INC.,, 120 WEST 45TH STREET, 17TH FLOOR, NEW YORK, NY, 10036.

Insiders trading at Schrodinger

Over the last 5 years, insiders at Schrodinger have traded over $1,009,056,149 worth of Schrodinger stock and bought 838,235 units worth $14,249,995 . The most active insiders traders include & Melinda Gates Foundation ..., David E Schrodinger Equity ..., eMichael Lynton. On average, Schrodinger executives and independent directors trade stock every 10 days with the average trade being worth of $2,459,207. The most recent stock trade was executed by Kenneth Patrick Lorton on 6 March 2024, trading 5,574 units of SDGR stock currently worth $24,191.

What does Schrodinger do?

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Complete history of Mr. Brauner stock trades at Schrodinger

Schrodinger executives and stock owners

Schrodinger executives and other stock owners filed with the SEC include:

• Dr. Ramy Farid Ph.D.,
  CEO, Pres & Director
• Yvonne Tran Esq.,
  Exec. VP, Chief Legal Officer & Sec.
• Dr. Karen Akinsanya Ph.D.,
  Exec. VP, Chief Biomedical Scientist and Head of Discovery R&D
• Ramy Farid,
  President, Chief Executive Officer, Director
• Cony D cruz,
  Executive Vice President - Chief Business Officer
• Yvonne Tran,
  Executive Vice President, Chief Legal Officer
• Dr. Richard A. Friesner,
  Co-Founder, Scientific Advisory Chairman and Director
• Richard Friesner,
  Independent Director
• Nancy Thornberry,
  Independent Director
• Gary Sender,
  Independent Director
• Rosana Kapeller-Libermann,
  Independent Director
• Timothy Wright,
  Independent Director
• Shane Brauner,
  Senior Vice President, Chief Information Officer
• Kenneth Lorton,
  Senior Vice President, Chief Technology Officer
• Karen Akinsanya,
  Executive Vice President, Chief Biomedical Scientist, Head of Discovery R&D
• Robert Abel,
  Executive Vice President - science
• Jorg Weiser,
  Executive Vice President, Managing Director
• Jennifer Daniel,
  Chief Human Resource Officer, Senior Vice President
• Joel Lebowitz,
  Executive Vice President, Chief Financial Officer
• Michael Lynton,
  Independent Chairman of the Board of Directors
• Michelle Byington,
  VP of HR
• Jennifer Mayer Daniel,
  Sr. VP & Chief HR Officer
• Jaren Irene Madden,
  Sr. VP of Investor Relations & Corp. Communications
• Shane Brauner,
  Exec. VP & Chief Information Officer
• Kenneth Patrick Lorton,
  Exec. VP & CTO
• Prof. William Goddard III,
  Co-Founder & Scientific Advisor
• Charles Ardai,
  10% owner
• Geoffrey Craig Porges,
  EVP & CFO
• David E Shaw,
  10% owner
• Gary L Ginsberg,
  Director
• Jeffrey Chodakewitz,
  Director
• & Melinda Gates Foundation ...,
  10% owner
• David E Schrodinger Equity ...,
  
• James E Deerfield Mgmt Iv, ...,
  
• Jenny Herman,
  SVP & Controller
• Arun Oberoi,
  Director
• Margaret Dugan,
  Chief Medical Officer